Showing results (1-10 of 537) with videos related to
Sort By:
Pageof 54
Cancer Clinical Trials|January 1, 1981
Acivicin. An antitumor antibioticD S Poster, S Bruno, J Penta, et al.Cancer Treatment Reports|January 1, 1981
Indicine-N-oxide: a new antitumor agentD S Poster, S Bruno, J Penta, et al.Cancer Clinical Trials|January 1, 1981
Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid glandD S Poster, S Bruno, J Penta, et al.Cancer Clinical Trials|January 1, 1980
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159D S Poster, J Penta, S Marsoni, et al.Cancer Treatment Reports|November 1, 1979
Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycinG L Neil, S L Kuentzel, J P McGovrenThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicinJ P McGovren, G L Neil, P J Chan, et al.American Journal of Clinical Oncology|February 1, 1982
PCNU: a new nitrosourea in clinical oncologyD S Poster, J S Penta, S BrunoCancer Research|June 1, 1977
Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159)J P McGovren, G L Neil, S L Crampton, et al.Cancer Treatment Reports|April 1, 1980
Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemiaJ P McGovrenJAMA|May 22, 1981
delta 9-tetrahydrocannabinol in clinical oncologyD S Poster, J S Penta, S Bruno, et al.Pageof 54